Neuropathology of Drug Addictions and Substance Misuse. Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions

Content: 
Front Matter,Copyright,List of Contributors,Preface,AcknowledgmentsEntitled to full textPart I: Principles of Addictions, Overviews, Detailed Processes and MechanismsSection A: General AspectsChapter 1 - Drugs and the Human Envirome, Pages 5-16, James C. Anthony
Chapter 2 - Psychoactive Plants Used during Religious Rituals, Pages 17-28, H. Umit Sayin
Chapter 3 - Substance Use Disorders and Comorbid Mental Illness: A Focus on Epidemiological Data Regarding Mood and Anxiety Disorders, Pages 29-39, Shaul Lev-Ran, Daniel Feingold, Jonah Fox
Chapter 4 - Mephedrone and Mephedrone-Based Cocktails: Market, Analysis, Mechanisms of Action, and Toxicity, Pages 40-49, Francesco S. Romolo, Paola A. Fiore, Edoardo Bottoni, Simone Cappelletti, Mariarosaria Aromatario, Costantino Ciallella
Chapter 5 - Substance-Induced Psychosis: Conceptual and Diagnostic Challenges in Clinical Practice, Pages 50-57, Melissa A. Weibell, Wenche ten Velden Hegelstad, Jan Olav Johannessen
Chapter 6 - Sleep and Drug Addiction, Pages 58-67, Laís F. Berro, Leonard L. Howell, Sergio Tufik, Monica L. Andersen
Chapter 7 - Hypothalamic and Midbrain Cells, Tyrosine Hydroxylase, and Implications for Drug Addiction, Pages 71-81, Grażyna Jerzemowska
Chapter 8 - Oxytocin: Providing New Avenues for Treating and Understanding Problematic Drug Use, Pages 82-92, Michael T. Bowen, Jiajun Liu, Femke T.A. Buisman-Pijlman
Chapter 9 - Role of D2-like Heteroreceptor Complexes in the Effects of Cocaine, Morphine, and Hallucinogens, Pages 93-101, Dasiel O. Borroto-Escuela, Karolina Wydra, Luca Ferraro, Alicia Rivera, Malgorzata Filip, Kjell Fuxe
Chapter 10 - Glutamate Receptors and Drug Addiction, Pages 102-110, M. Foster Olive
Chapter 11 - Effect of Interacting Nonsteroidal Anti-Inflammatory Agents (NSAIDs) and Opioids on Mood: Pharmacodynamic Considerations in Misuse and Abuse, Pages 111-119, Mirko Manchia, Martina Pinna, Eileen M. Denovan-Wright
Chapter 12 - A Mini-Review on Different Commonly Used Abusive Drugs and the Interactions of These Drugs and Chinese Herbs, Pages 120-128, Yemina Chung, Andrew W.S. Yong, Willmann Liang, Hong Chai Tang, Maria S.M. Wai, David T. Yew
Chapter 13 - Interaction of Drugs of Addiction with DNA, Pages 129-136, Ali A. Ensafi, Esmaeil Heydari-Bafrooei
Chapter 14 - Drugs of Abuse and DNA Methylation in the Brain: Ethanol, Cocaine, Amphetamine–Methamphetamine, Heroin, Antidepressants, and Antipsychotics, Pages 137-143, Domniki Fragou, Leda Kovatsi
Chapter 15 - Orexin/Hypocretin System and Drug Addiction, Pages 144-152, Alessandra Matzeu, Rémi Martin-Fardon
Chapter 16 - Reverse Translational Implications of Genome-Wide Association Studies for Addiction Genetics, Pages 153-164, F. Scott Hall
Chapter 17 - Polymorphisms in the Delta Opioid Receptor Gene (OPRD1) and Drug Addiction: Candidate Genes, Transgenic Mouse Models, and Genome-Wide Association Studies, Pages 165-175, Florence F. Roussotte, Paul M. Thompson
Chapter 18 - Drug Addictions and Genetics of the Dopamine Pathway, Pages 176-182, Yann Le Strat, Nicolas Ramoz, Philip Gorwood
Chapter 19 - In Silico Chemogenomics Knowledgebase and Computational System Neuropharmacology Approach for Cannabinoid Drug Research, Pages 183-195, Xiang-Qun Xie, Lirong Wang, Junmei Wang, Zhaojun Xie, Peng Yang, Qin Ouyang
Chapter 20 - Cocaine- and Amphetamine-Regulated Transcript (CART) Peptide and Drug Addiction, Pages 196-205, Martin O. Job
Chapter 21 - The Cerebellar Landscape of Drug Addiction, Pages 209-218, Marta Miquel, Dolores Vazquez-Sanroman, María Carbo-Gas, Isis Gil-Miravet, Carla Sanchis-Segura
Chapter 22 - Movement Dysfunction as a Neuropathology of Illicit Stimulant Abuse, Pages 219-228, Verity Pearson-Dennett, Robert A. Wilcox, Jason M. White, Gabrielle Todd
Chapter 23 - Left Hemispheric “Imbalance” in Drug Addiction, Pages 229-238, Michela Balconi, Roberta Finocchiaro
Chapter 24 - Co-occurence of Substance Use and Personality Disorders: Epidemiology, Etiopathogenesis, and Treatment, Pages 239-248, Paola Casadio, Deanna Olivoni, Roberta Bonafede, Anna Rita Atti
Chapter 25 - Neonatal Abstinence Syndrome: Pharmacological Aspects, Pages 249-257, Kathleen Kopcza, Rachana Singh
Chapter 26 - Comorbidity between Substance Use Disorder and Severe Mental Illness: Dual Diagnosis, Pages 258-268, Ana Adan, Irina Benaiges
Chapter 27 - Lormetazepam Addiction, Pages 273-282, Lara Magro, Marco Faccini, Roberto Leone
Chapter 28 - Prescribing and Dispensing of Benzodiazepines: Implications for Dependence and Misuse, Pages 283-292, M. Mofizul Islam, Suzanne Nielsen, Ian S. McRae, Paul S. Haber, Apo Demirkol, Bridin Murnion, Hester Wilson, Katherine M. Conigrave
Chapter 29 - Bidirectional Plasticity of Hippocampal Glutamate Receptors Is Central to Expression of Benzodiazepine Withdrawal-Anxiety, Pages 295-307, Elizabeth I. Tietz
Chapter 30 - Effect of Chronic Benzodiazepine Exposure on GABAA Receptors: Regulation of GABA/Benzodiazepine Site Interactions, Pages 308-316, María Clara Gravielle
Chapter 31 - The K+-Cl− Cotransporter KCC2 and Zolpidem, Pages 317-324, Masahiro Shibasaki, Tomohisa Mori, Tsutomu Suzuki
Chapter 32 - Benzodiazepine Misuse and Addiction. Risk Factors and Adverse Behavioral Aspects, Pages 327-333, Anna Konopka, Justyna Pełka Wysiecka, J. Samochowiec
Chapter 33 - Benzodiazepines, Age-Related Pharmacological Changes, and Risk of Falls in Older Adults, Pages 334-344, Anna Lukačišinová Ballóková, Daniela Fialová
Chapter 34 - The Substantia Nigra Pars Reticulata in Sedative-Hypnotic Withdrawal, Pages 345-355, Lauren C. Kruse, Kari J. Buck
Chapter 35 - Assays for Benzodiazepines, Pages 359-370, Elisabetta Bertol, Fabio Vaiano
Chapter 36 - Weak Opioid Analgesics Abuse and Addiction: A Comparison of the Pharmacology and Pharmacoepidemiology of Codeine, Dihydrocodeine, and Tramadol, Pages 375-391, Anne Roussin, Aurore Palmaro, Maryse Lapeyre-Mestre
Chapter 37 - Maternal Codeine and Its Effect on the Fetus and Neonate: A Focus on Pharmacogenomics, Neuropathology, and Withdrawal, Pages 392-398, Amuchou Singh Soraisham
Chapter 38 - Methadone Usage, Misuse, and Addiction Processes: An Overview, Pages 399-406, Zia Li, Zheng-Xiong Xi
Chapter 39 - Tramadol, Usage, Misuse, and Addiction Processes, Pages 407-416, Behjat Sheikholeslami, Bardia Jamali, Mohammadreza Rouini
Chapter 40 - Tramadol Abuse in the Elderly, Pages 417-422, Ebru Findikli, Hatice Altun
Chapter 41 - Oligodendrocyte Responses, Myelination, and Opioid Addiction Treatments, Pages 425-432, Carmen Sato-Bigbee, Susan E. Robinson
Chapter 42 - Opioids and TRPV1 Receptors, Pages 433-442, Ali Roohbakhsh, Ali Shamsizadeh
Chapter 43 - Opioids and Serotonin Syndrome: An Example with Tramadol, Pages 443-448, Brian A. Falls
Chapter 44 - Opioid Dependence and the Adenylyl Cyclase/cAMP Signaling, Pages 449-456, Hai-Yu Yang, Bhushan Vijay Nagpure, Jin-Song Bian
Chapter 45 - Central Nervous System Penetration of the Opioid Oxycodone, Pages 457-466, Hannu Kokki, Merja Kokki
Chapter 46 - Opioid Modulation of Voltage-Gated Calcium Currents, Pages 467-475, Enrique Soto, Emmanuel Seseña, Rosario Vega
Chapter 47 - The Neonatal Brain and Opioids, Pages 476-481, Preeta George, Robert Moore
Chapter 48 - Contribution of Spinal Cord mTORC1 to Chronic Opioid Tolerance and Hyperalgesia, Pages 482-489, Linlin Sun, Brianna M. Lutz, Yuan-Xiang Tao
Chapter 49 - Interaction of Codeine with DNA, Pages 490-496, Ali A. Ensafi, Maryam Amini, Esmaeil Heydari-Bafrooei
Chapter 50 - Fentanyl and Its Impact on Cell Functions, Pages 497-507, Kiichi Hirota
Chapter 51 - Morphine and Trafficking of a Mu Opioid Receptor Interacting Protein WLS, Pages 508-516, Beverly A.S. Reyes, Wade H. Berrettini, Nicole M. Enman, Elisabeth J. Van Bockstaele
Chapter 52 - Fas, Bcl-2, and Caspase-3 Protein and Morphine Addiction, Pages 517-524, Liwei Liu, Jingsheng Lou, Qiang Fu
Chapter 53 - An Overview on Methadone-Intoxicated Patients, Pages 525-531, Hossein Hassanian-Moghaddam, Nasim Zamani
Chapter 54 - Genetic Polymorphisms on OPRM1 Involved in Multiple Responses of a Methadone Maintenance Population: Relationships with Insomnia, Libido, Smoking, and Chemokines, Pages 532-541, Yu-Li Liu, Jieh-Hen Tsung, Chiu-Ping Fang, Sheng-Wen Liu, Chien-Wen Lai, Chieh-Liang Huang, Sheng-Chang Wang
Chapter 55 - Modulation of Opioid Analgesic Reward by Inflammatory Agents, Pages 545-554, Kristen A. Hymel, Jason J. Paris, Jay P. McLaughlin
Chapter 56 - Suicidal Behavior and Prescription Opioid Medication, Pages 555-566, Veronica B. Searles Quick, Jonathan M. Davis
Chapter 57 - Codeine and Psychomotor Activity, Pages 567-576, Marie-Laure Bocca
Chapter 58 - Neurobehavior of Neonates Born to Mothers Receiving Opioid Maintenance Treatment: Methadone and Buprenorphine, Pages 577-588, Trecia A. Wouldes
Chapter 59 - Prenatal Methadone and Behavioral Sensitization Induced by Methamphetamine, Pages 589-594, Lir-Wan Fan, Lu-Tai Tien
Chapter 60 - Treatments for Opioid Dependence and Methadone: Neurological and Behavioral Aspects, Pages 595-602, M.T. Bobes-Bascarán, M.T. Bascarán, S. Al-Halabí, P.A. Saiz, M. Bousoño, M.P. García-Portilla, J. Bobes
Chapter 61 - Cognitive Functioning in Methadone Use, Pages 603-607, Michael Soyka
Chapter 62 - Sleep Disturbances in Methadone Maintenance Treatment (MMT) Patients, Pages 608-615, Nan-Ying Chiu, Wen-Yu Hsu
Chapter 63 - The Neuropathology of Drug Addictions and Substance Misuse: Assays for Fentanyl, Pages 619-630, Koichi Inoue, Motoo Nomura
Chapter 64 - Assays for Tramadol and Its Metabolites, Pages 631-645, Behjat Sheikholeslami, Meshkat Torkamanian, Yalda Hosseinzadeh Ardakani, Bardia Jamali, Mohammadreza Rouini
Chapter 65 - Methylphenidate Abuse: An Overview, Pages 651-659, Maximilian Gahr, Paul L. Plener
Chapter 66 - The Impact of Methylphenidate on Circadian Rhythms and Clock Gene Expression, Pages 663-672, Andrew N. Coogan, Johannes Thome, Alison L. Baird
Chapter 67 - The Characteristics of Acute and Chronic Methylphenidate, Dose, and Route on Female and Male Animal Behavior, Pages 675-681, Nachum Dafny
Chapter 68 - Methylphenidate and Cognitive Performance, Pages 682-691, Eldad Yechiam, Nirit Agay
Chapter 69 - Methylphenidate and Suicide, Pages 692-698, Priti Arun, Subhash Das
Chapter 70 - The Effect of Methylphenidate on the Ventral Tegmental Area in Adolescent and Adult Animals, Pages 699-706, Natasha Kharas, Nachum Dafny
Chapter 71 - Dextromethorphan and Dextrorphan as Heuristic Rapid-Acting, Conventional, and Treatment-Resistant Antidepressants, with Substance Abuse Considerations, Pages 707-717, Edward C. Lauterbach, Samuel D. Shillcutt, Daniel E. Phillips
Chapter 72 - Caffeine and Taurine and Energy Drink Abuse, Pages 723-732, Rocco S. Calabrò, Antonino Naro, Placido Bramanti
Chapter 73 - General Aspects of Areca Nut Addiction, Pages 733-737, Ahsana Dar Farooq, Ghulam Abbas
Chapter 74 - Caffeine, Adenosine A1 Receptors, and Brain Cortex. Molecular Aspects, Pages 741-752, Antoni Cortés, Verònica Casadó-Anguera, Estefanía Moreno, Vicent Casadó
Chapter 75 - Caffeine and the Developing Brain: Molecular and Cellular Effects, Pages 753-761, Anzari Atik, Richard Harding, Robert De Matteo, Mary Tolcos
Chapter 76 - Effects of Caffeine and Its Cortical Response Studied by Functional Brain Imaging, Pages 765-774, Zang-Hee Cho, Chang-Ki Kang, Chan-A Park, Young-Bo Kim
Chapter 77 - Neurobehavioral Aspects of Caffeine, Pages 775-784, Robert N. Hughes
Chapter 78 - Oral and Systemic Health Effects of Compulsive Areca Nut Use, Pages 785-793, Stephen Cox, Mafaz Ullah, Hans Zoellner
Chapter 79 - Areca Alkaloids and Schizophrenia, Pages 794-802, Maurizio Coppola, Raffaella Mondola, Francesco Oliva, Rocco Luigi Picci
Chapter 80 - Attentional Biases for Betel Nut Cues, Pages 803-812, Ming-Chou Ho, Bin Shen, Meng-Chun Chiu, Ling-Jun Liu, Ren-Hau Li, Tze-Chun Tang
Chapter 81 - Quantitative Measurement of Caffeine by Optical Methods, Pages 815-826, Wang Xu, Young-Tae Chang
Chapter 82 - Betel Quid Dependence Scale, Pages 827-835, Chen-Yi Lee, Thaddeus A. Herzog, Kelle L. Murphy, Yong-Yuan Chang
Chapter 83 - Types of Polydrug Usage, Pages 839-849, Olga Hernández-Serrano, Maria Eugènia Gras, Sílvia Font-Mayolas, Mark J.M. Sullman
Chapter 84 - Polypharmacy of Potentially Addictive Medications and the Elderly, Pages 850-859, C. Ineke Neutel, Helen J. Johansen
Chapter 85 - New Insight into Alcohol and Nicotine Addiction: Neurobiological Findings and Therapeutical Perspectives, Pages 860-871, Mario Vitali, Gemma Battagliese, Mauro Ceccanti
Chapter 86 - Multimodal Magnetic Resonance Neuroimaging and Cognition in Polysubstance Users, Pages 872-883, Dieter J. Meyerhoff
Chapter 87 - Neuropathological Studies in Polydrug Abusers, Pages 884-889, Andreas Büttner
Chapter 88 - Novel Drugs of Abuse: Cannabinoids, Stimulants, and Hallucinogens, Pages 893-902, Evan S. Herrmann, Patrick S. Johnson, Matthew W. Johnson, Ryan Vandrey
Chapter 89 - Kratom (Mitragyna speciosa) Use, Addiction Potential, and Legal Status, Pages 903-911, Dessa Bergen-Cico, Kendra MacClurg
Chapter 90 - Methylxanthines and Drug Dependence: Interactions and Toxicity, Pages 912-923, Giulia Costa, Micaela Morelli, Nicola Simola
Chapter 91 - The Neuropathology of Movement Disorders in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) and Methcathinone (Ephedrone) Addictions, Pages 924-934, Ainars Stepens, Pille Taba
Chapter 92 - 25C-NBOMe as a New Hallucinogen, Pages 935-944, Dariusz Zuba, Piotr Adamowicz, Simon Elliott
Chapter 93 - Pregabalin Abuse and Addiction, Pages 945-951, Giovanni Martinotti, Georgios Papazisis, Rita Santacroce, Dimitrios Kouvelas, Eduardo Cinosi, Matteo Lupi, Massimo di Giannantonio
Chapter 94 - Internet Gaming Disorder, Pages 955-961, Doug Hyun Han, Gi Jung Hyun, Jeong Ha Park, Perry F. Renshaw
Chapter 95 - The Neuropathology of Internet Addiction, Pages 962-971, Sevim Karakaş-Çelik, Tuba Edgunlu, Ömer Şenormanci, Ulaş M. Çamsari
Chapter 96 - Workaholism: An Addiction to Work, Pages 972-983, Cecilie Schou Andreassen, Ståle Pallesen
Chapter 97 - Exercise Addiction, Pages 984-992, Attila Szabo, Mark D. Griffiths, Zsolt Demetrovics
Chapter 98 - Compulsive Buying—Features and Characteristics of Addiction, Pages 993-1007, Aviv Weinstein, Aniko Maraz, Mark D. Griffiths, Michel Lejoyeux, Zsolt Demetrovics
Chapter 99 - Food Addiction: Applying Substance Use Disorder Criteria and Characteristics to Identify Instances of Addictive-Like Eating, Pages 1008-1018, Miriam E. Bocarsly
Chapter 100 - Bulimia Nervosa as an Addiction, Pages 1019-1027, Natalie A. Hadad, Lori A. Knackstedt
Chapter 101 - Gambling Disorders: A Focus on Genetic Aspects, Pages 1028-1038, Rida Hashmi, Daniela S.S. Lobo
Index, Pages 1039-1068